Paglialunga, M.; Flamini, S.; Contini, R.; Febo, M.; Ricci, E.; Ronchetti, S.; Bereshchenko, O.; Migliorati, G.; Riccardi, C.; Bruscoli, S.
Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs). Cells 2023, 12, 2294.
https://doi.org/10.3390/cells12182294
AMA Style
Paglialunga M, Flamini S, Contini R, Febo M, Ricci E, Ronchetti S, Bereshchenko O, Migliorati G, Riccardi C, Bruscoli S.
Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs). Cells. 2023; 12(18):2294.
https://doi.org/10.3390/cells12182294
Chicago/Turabian Style
Paglialunga, Musetta, Sara Flamini, Raffaele Contini, Marta Febo, Erika Ricci, Simona Ronchetti, Oxana Bereshchenko, Graziella Migliorati, Carlo Riccardi, and Stefano Bruscoli.
2023. "Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)" Cells 12, no. 18: 2294.
https://doi.org/10.3390/cells12182294
APA Style
Paglialunga, M., Flamini, S., Contini, R., Febo, M., Ricci, E., Ronchetti, S., Bereshchenko, O., Migliorati, G., Riccardi, C., & Bruscoli, S.
(2023). Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs). Cells, 12(18), 2294.
https://doi.org/10.3390/cells12182294